Core Insights - Sichuan Province is actively developing emerging and future industries, focusing on technological innovation to drive industrial upgrades and cultivate new economic growth drivers [1][2][4] Group 1: Policy and Strategic Initiatives - In July, Sichuan issued an implementation plan for developing emerging industries and accelerating the cultivation of future industries from 2025 to 2027, aiming to create an innovation-driven industrial cultivation chain [1] - The province has established a project scheduling mechanism to facilitate the development of emerging industries, ensuring a conducive business environment [2][3] Group 2: Industry Development and Performance - Suining is positioning itself as the "Lithium Battery Capital," with the lithium new energy industry expected to achieve a year-on-year increase of 21.3% in added value in 2024, contributing 86.8% to industrial added value growth [1] - The Tianqi Lithium project in Suining is a key part of the local lithium battery industry chain, enhancing the lifecycle from lithium resource development to comprehensive recycling [1] Group 3: Investment and Project Management - From January to August, Sichuan's fixed asset investment grew by 0.9%, with project investment increasing by 2.6%. As of the end of August, 810 key projects in Sichuan had an annual investment completion rate of 84.6% [4] - The establishment of the "Tianfu Project Pass" smart management platform aims to enhance project management efficiency and service levels [3]

这一总投资超8000万元的基因药物生产基地，占地38亩，于2025年2月7日启动建设，从开工到验收仅用时半年多，设计年产能为10万支。谢清 表示，在该基地建设过程中，相关部门组建服务专班，仅用1个月时间就将报批报建手续全部办完，确保了项目早开工、早建成。 2025年进入最后一个季度，成都迅速切换"冲刺模式"，一边通过"熊猫消费节"等节庆活动推高消费热度，一边推进重大产业化项目提速建设。 这也成为四川"攻坚四季度"的直观体现。 10月13日上午，成都火车站扩能改造工程现场，高耸的塔吊正有序运转。《每日经济新闻》记者从现场获悉，改造后，成都站站场规模10台18 线，预计2027年与成渝中线高铁同步开通，将整合高铁、市域铁路、地铁（1号线、7号线和18号线）、公交等交通方式，实现"立体交叉零换 乘"。 "目前我们处于第三阶段施工，主要施工9至18道站房基础及结构，成都站扩能改造工程已完成整体进度的60%以上。"中国铁路成都局集团有 限公司客站建设指挥部副指挥长聂兆希表示，扩能改造工程现场目前有1500人以上施工，同时投入超30台大型机械，明年春节期间，第三阶段 工程将初具雏形。 随着这些重点基础设施项目以及产业化项 ...

Core Viewpoint - Bayer is committed to enhancing its focus and resource investment in China's innovation ecosystem, aiming to collaborate with local innovators to discover the next significant breakthroughs in drug development [1]. Group 1: Competition Announcement - Bayer China has officially launched the "Co-Creation New Drug" competition, inviting Chinese innovators and biotechnology companies to submit and showcase their innovative research pipelines, drug molecules, or new technologies with breakthrough potential [1]. Group 2: Target Therapeutic Areas - The competition focuses on several key therapeutic areas, including: - Precision Oncology - Precision Cardiorenal Diseases - Immunology & Inflammation [2]. Group 3: Research Pipeline Stages - The competition accepts submissions at various stages of the research pipeline, ranging from early pre-clinical candidate compounds (pre-PCC) to clinical proof of concept (clinical PoC) [2]. Group 4: Drug Molecule Forms - Eligible drug molecule forms include: - Biologics - Small molecules (SMOL) - Conjugated drugs (XDC) - Genetic medicine - Small nucleic acid drugs (siRNA) - Molecular glue - Other platform technologies [3]. Group 5: Evaluation Criteria - Submissions will be evaluated by a review committee composed of Bayer China's and global R&D and business development experts based on innovation level, key data, advancement speed, and alignment with Bayer's R&D strategy [4].

Group 1 - The 27th China Beijing International Science and Technology Industry Expo (Beijing Sci-Tech Expo) will be held from May 8 to 11 at the National Convention Center, featuring a doubled exhibition area of approximately 50,000 square meters and over 800 participating enterprises and institutions [1][3] - The theme of this year's expo is "Technology Leading, Creating a Future," focusing on cutting-edge technology, emerging industries, and future industries, aiming to deepen international cooperation in technology and promote the integration of innovation, industry, finance, and talent [1][2] - A variety of activities will take place during the expo, including trade and investment promotion events, online display and matching, and a series of specialized forums and promotional meetings [3] Group 2 - The expo will showcase original achievements in foundational technologies such as quantum computing, gene editing, and flexible sensing technology, along with innovative products like room-temperature quantum computers and gene therapies for hereditary diseases [2] - Notable exhibits will include over 400 new achievements from the "Three Cities and One Area" and various sub-parks of Zhongguancun, featuring advanced technologies like reusable rockets and cutting-edge ophthalmic diagnostic equipment [2] - The upgraded online negotiation system will incorporate AI models to provide smarter and more precise services for participants, enhancing the overall experience of the expo [3]